Atopic Neutrophils Prevent Postviral Airway Disease

Area of Science:

• Immunology
• Respiratory Medicine
• Allergy Research

Background:

• Respiratory syncytial virus (RSV) infection in infancy increases asthma risk.
• Infants with pre-existing allergic disease are an exception to this increased risk.
• The mechanisms underlying this protective effect remain unclear.

Purpose of the Study:

• To investigate the role of pre-existing atopy in modulating post-respiratory viral airway disease.
• To elucidate the cellular and molecular mechanisms behind atopy-mediated protection against viral-induced airway inflammation.

Main Methods:

• Utilized a mouse model (Sendai virus) mimicking human RSV infection.
• Examined the impact of pre-existing atopy (induced by house dust mite allergen) on post-viral airway disease.
• Investigated the role of neutrophils and IL-4 in the protective mechanism through cell depletion and systemic inhibition.

Main Results:

• Pre-existing atopy protected mice against Sendai virus-induced airway disease.
• Neutrophil depletion abolished this protective effect, restoring susceptibility in atopic mice.
• Atopy was associated with increased IL-4-dependent neutrophil-dendritic cell hybrid formation and enhanced viral uptake.
• Human neutrophils from atopic donors demonstrated reduced RSV infection of airway epithelial cells in vitro.

Conclusions:

• Pre-existing atopy confers protection against post-viral airway disease.
• This protection is mediated by an IL-4-dependent neutrophil response that enhances viral uptake.
• Findings suggest a potential therapeutic strategy involving neutrophils and IL-4 modulation for preventing post-RSV asthma.